Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for InspireMD Inc. (NSPR:NASDAQ), powered by AI.
InspireMD Inc. is currently trading at $0.71. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for InspireMD Inc. on Alpha Lenz.
View InspireMD Inc.'s valuation metrics on Alpha Lenz.
“InspireMD Inc.'s ROE is -106.9%. Explore profitability and growth together.”
Ask for details →InspireMD Inc. is a leading medical device company focusing on innovative embolic prevention systems and neurovascular devices. Its primary mission is to improve the outcome of vascular procedures with its proprietary MicroNet™ technology, which is designed to significantly improve the efficacy and safety of stenting procedures. InspireMD is particularly influential in the interventional cardiology and neurovascular sectors, targeting severe cardiovascular conditions such as carotid artery disease and coronary artery disease. The company is headquartered in Tel Aviv, Israel, and serves a global market, distributing its products in numerous countries. As a key player in the medical device industry, InspireMD strives to reduce the risks associated with stenting, such as embolization and restenosis, thus aiming to enhance patient care and safety in critical medical interventions. Its commitment to advancing medical technology makes InspireMD a pivotal entity in the ongoing effort to innovate and improve healthcare delivery worldwide.
“InspireMD Inc.'s ROE is -106.9%. Explore profitability and growth together.”
Ask for details →InspireMD Inc. (ticker: NSPR) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 66 employees.
The current price is $0.712 with a P/E ratio of -x and P/B of -x.
ROE is -106.88% and operating margin is -552.56%. Annual revenue is $9M.